| Name | Value |
|---|---|
| Revenues | 721.7M |
| Cost of Revenue | 365.2M |
| Gross Profit | 356.5M |
| Operating Expense | 277.9M |
| Operating I/L | 78.6M |
| Other Income/Expense | 6.8M |
| Interest Income | 2.6M |
| Pretax | 71.6M |
| Income Tax Expense | 19.8M |
| Net Income/Loss | 50.9M |
Bruker Corporation is a global leader in developing, manufacturing, and distributing scientific instruments, analytical, and diagnostic solutions. The company's three segments, Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies, offer a wide range of products including life science tools, mass spectrometry systems, molecular diagnostics kits, analytical instruments, SARS-CoV-2 testing solutions, portable analytical detection systems, X-ray instruments, atomic force microscopy instrumentation, and advanced optical fluorescence microscopy instruments. Additionally, Bruker provides superconducting materials, devices, and non-superconducting high technology tools. The company generates revenue through the sale of these scientific instruments and solutions to customers worldwide.